1.Retrospective Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 88 Chinese Patients.
Chinese Medical Journal 2017;130(9):1062-1068
BACKGROUNDStevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening diseases with high mortality rates. This study was designed to analyze the pathogenic factors, clinical manifestations, complications, treatment, and prognosis of SJS/TEN and to explore the differences between surviving and deceased patients.
METHODSSJS/TEN patients admitted to Beijing Friendship Hospital from January 2006 to December 2015 were included in the study. Patients' data were retrospectively analyzed. Comparative studies were performed on the survival group and the deceased group, and Fisher's exact probability test was used for statistical analysis.
RESULTSAmong the 88 patients included, 40 (45.5%) were male with a mean age of 45 ± 18 years. Forty-eight (54.5%) had SJS, 34 (38.6%) had SJS/TEN, and 6 (6.8%) had TEN. Fifty-three (60.2%) cases were caused by medications, mainly antibiotics (n = 24) followed by traditional Chinese medicines (n = 7). Forty-two cases (47.7%) developed visceral damage. Eighty-two patients improved or recovered and were discharged from hospital, and six patients died. Comparative studies on the survival group and the deceased group showed that the presence of malignant tumor ( χ2 = 27.969,P < 0.001), connective tissue diseases ( χ2 = 9.187, P= 0.002), previous abnormal liver/kidney functions ( χ2 = 6.006, P= 0.014), heart rate >100 times/min ( χ2 = 6.347, P= 0.012), detached skin area >20% ( χ2 = 5.594, P= 0.018), concurrent mucosal involvement at the mouth, eyes, and external genitals ( χ2 = 4.945, P= 0.026), subsequent accompanying liver/kidney damage ( χ2 = 11.839, P= 0.001, and χ2 = 36.302,P < 0.001, respectively), and SCORTEN score >2 ( χ2 = 37.148,P < 0.001) increased the risk of death.
CONCLUSIONSSJS/TEN is mainly caused by medications, and nearly half of patients develop visceral damage. Multiple factors increase the mortality risk.
Adult ; Anti-Bacterial Agents ; therapeutic use ; Connective Tissue Diseases ; metabolism ; pathology ; Eye ; pathology ; Female ; Genitalia ; pathology ; Humans ; Kidney ; metabolism ; pathology ; Liver ; metabolism ; pathology ; Male ; Middle Aged ; Mouth ; pathology ; Retrospective Studies ; Skin ; metabolism ; pathology ; Stevens-Johnson Syndrome ; drug therapy ; metabolism ; pathology
2.Liver dysfunction induced by systemic hypersensitivity reaction to lamotrigine: case report.
Sung Gyu IM ; Sun Hong YOO ; Young Min PARK ; Sang Jin LEE ; Sun Kyung JANG ; Dong Ok JEON ; Hyo Jin CHO ; Mi Jung OH
Clinical and Molecular Hepatology 2015;21(2):180-182
Lamotrigine is an anticonvulsant drug used to treat partial and generalized seizure disorders. Hypersensitivity to lamotrigine usually causes mild symptoms such as fever, rash, and slight invasion of internal organs. However, a 33-year-old male patient who was admitted with Stevens-Johnson syndrome after taking lamotrigine for 15 days experienced hepatic failure and died 5 days after admission. This case demonstrates the importance of realizing that lamotrigine can lead to fatal hepatic failure, and that tests for the normal liver function should be performed when administering lamotrigine.
Adult
;
Alanine Transaminase/blood
;
Anticonvulsants/*adverse effects/therapeutic use
;
Aspartate Aminotransferases/blood
;
Drug Hypersensitivity/complications/*diagnosis
;
Humans
;
Liver/enzymology/metabolism
;
Liver Failure/*etiology
;
Male
;
Stevens-Johnson Syndrome/diagnosis/drug therapy
;
Triazines/*adverse effects/therapeutic use
3.Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management
Evy YUNIHASTUTI ; Alvina WIDHANI ; Teguh Harjono KARJADI
Asia Pacific Allergy 2014;4(1):54-67
Human immunodeficiency virus (HIV)-infected patients present complex immunological alterations. Multiple drugs that usually prescribed for prevention or treatment of opportunistic infections and antiretroviral pose these patients a higher risk of developing drug hypersensitivity. All antiretroviral agents and drugs to treat opportunistic infections have been reported to cause drug hypersensitivity reactions. Allergic reactions with antiretroviral are not restricted to older agents, although newer drugs usually more tolerated. Cutaneous adverse drug reactions are the most common manifestation of drug hypersensitivity in HIV, typically manifesting as maculopapular rash with or without systemic symptoms in the presence or absence of internal organ involvement. The onset of an allergic reaction is usually delayed. Severe drug hypersensitity reactions as erythema multiforme, Stevens Johnson syndrome and toxic epidermal necrolysis develop more often in HIV-infected patients compared to other populations. Mild to moderate rash without systemic symptom or organ involvement usually do not need drug discontinuation. Appropriate diagnosis and management of drug hypersensitivity reactions are essential, especially in patients with very low CD4+ T-cell count and multiple opportunistic infections. Clinicians should aware of different half-life of each drug when decided to stop the drug. Knowledge of the metabolism, recognition of the risk factors, and the ability to suggest the probability of particular drug as causative are also important points. A step wise rechallenge test or desensitization with the offending drug might be a preferable action and more commonly used in managing drug hypersensitivity in HIV-infected patients. Desensitization protocols have been successfully done for several antiretroviral and opportunistic infection drugs.
Anti-Retroviral Agents
;
Diagnosis
;
Drug Hypersensitivity
;
Drug-Related Side Effects and Adverse Reactions
;
Erythema Multiforme
;
Exanthema
;
Half-Life
;
HIV
;
Humans
;
Hypersensitivity
;
Metabolism
;
Opportunistic Infections
;
Risk Factors
;
Stevens-Johnson Syndrome
;
T-Lymphocytes
4.Interleukin-17 in Various Ocular Surface Inflammatory Diseases.
Min Ho KANG ; Mee Kum KIM ; Hyun Joo LEE ; Hyeon Il LEE ; Won Ryang WEE ; Jin Hak LEE
Journal of Korean Medical Science 2011;26(7):938-944
Recently, the association of Th-17 cells or IL-17 with ocular inflammatory diseases such as uveitis, scleritis and dry eye syndrome was discovered. We assessed whether interleukin (IL)-17 was present in the tears of various ocular surface inflammatory diseases and the tear IL-17 concentrations were clinically correlated with various ocular surface inflammatory diseases. We measured concentrations of IL-17 in tears of normal subjects (n = 28) and patients (n = 141) with meibomian gland dysfunction (MGD), dry eye syndrome (DES), Sjogren syndrome (SS), Stevens-Johnson syndrome (SJS), graft-versus-host disease (GVHD), filamentary keratitis, and autoimmune keratitis associated with rheumatoid arthritis or systemic lupus erythematosus. Clinical epitheliopathy scores were based on the surface area of corneal and conjunctival fluorescein staining. The mean concentrations of IL-17 in tears of patients with filamentary keratitis, GVHD, autoimmune keratitis, SS, DES, MGD, SJS were significantly higher in order than that in normal subjects. Tear IL-17 concentration was significantly correlated with clinical epitheilopathy scores in the patients with systemic inflammatory disease, while tear IL-17 was not correlated with clinical severity of the cornea and conjunctiva in the dry eye patients without any systemic inflammatory disease. Tear IL-17 is likely to correlate clinically with corneal disease severity only in the patients with systemic inflammatory disease.
Adult
;
Aged
;
Dry Eye Syndromes/*metabolism
;
Eye Diseases/diagnosis/*metabolism
;
Eyelid Diseases/metabolism
;
Female
;
Graft vs Host Disease/metabolism
;
Humans
;
Interleukin-17/*analysis
;
Keratitis/metabolism
;
Male
;
Meibomian Glands/physiopathology
;
Middle Aged
;
Severity of Illness Index
;
Sjogren's Syndrome/metabolism
;
Stevens-Johnson Syndrome/metabolism
;
Tears/metabolism
5.Pharmacogenetics and its relevance to clinical practice.
Natalia SUTIMAN ; Balram CHOWBAY
Annals of the Academy of Medicine, Singapore 2013;42(9):429-431
Anticonvulsants
;
adverse effects
;
Aryl Hydrocarbon Hydroxylases
;
genetics
;
Asian Continental Ancestry Group
;
genetics
;
Camptothecin
;
analogs & derivatives
;
metabolism
;
Carbamazepine
;
adverse effects
;
Cytochrome P-450 CYP2C19
;
Glucuronosyltransferase
;
genetics
;
HLA-A Antigens
;
genetics
;
HLA-B Antigens
;
genetics
;
Humans
;
Platelet Aggregation Inhibitors
;
metabolism
;
Stevens-Johnson Syndrome
;
genetics
;
Ticlopidine
;
analogs & derivatives
;
metabolism
;
Topoisomerase I Inhibitors
;
metabolism